Noho's Cash & cash equivalent grew by % in the Q3 2014 sequentially, faster than Current Liabilities, this led to improvement in Noho's Quick Ratio to 0.02, Quick Ratio remained below Noho, Inc. average.

Within Biotechnology & Pharmaceuticals industry 78 other companies have achieved higher Quick Ratio than Noho in third quarter 2014. While Quick Ratio total ranking has improved so far during the Q3 2014 to 4476, from total ranking in the second quarter 2014 at 5506.

Explain Quick Ratio?
How much Cash & cash equivalents DRNK�s has?
What are DRNK�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

DRNK Quick Ratio	(Sep 30 2014) Q3	(Jun 30 2014) Q2	(Mar 31 2014) Q1	(Dec 31 2013) Q4	(Sep 30 2013) Q3
Y / Y Current Liabilities Change	92.35 %	52.42 %	1000.67 %	-	-
Y / Y Cash & cash equivalent Change	-51.19 %	-	-	6750.27 %	20192.3 %
Quick Ratio MRQ	0.02	-	-	0.02	0.08
DRNK's Total Ranking	# 4476	# 5506	# 5593	# 5593	# 3970
Seq. Current Liabilities Change	29.44 %	28.52 %	20.07 %	-3.7 %	2.57 %
Seq. Cash & cash equivalent Change	-	-	-	-74.51 %	-

Quick Ratio third quarter 2014 Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 79
Healthcare Sector	# 667
Overall Market	# 4476

Quick Ratio Statistics
High	Average	Low
0.08	0.04	0.02
(Sep 30 2013)		(Sep 30 2014)

Financial Statements
Noho's Current Liabilities	$ 4 Millions	Visit DRNK's Balance sheet
Noho's Cash & cash equivalent	$ 0 Millions	Visit DRNK's Balance sheet
Source of DRNK's Sales		Visit DRNK's Sales by Geography

Cumulative Noho's Quick Ratio

DRNK's Quick Ratio for the trailling 12 Months

DRNK Quick Ratio	(Sep 30 2014) 12 Months	(Jun 30 2014) 12 Months	(Mar 31 2014) 12 Months	(Dec 31 2013) 12 Months	(Sep 30 2013) 12 Months
Y / Y Current Liabilities TTM Growth	165.8 %	326.4 %	3797.38 %	-	-
Y / Y Cash & cash equivalent TTM Growth	-30.87 %	1472.12 %	1001.72 %	2934.01 %	2344.87 %
Quick Ratio TTM	0.01	0.02	0.02	0.03	0.04
Total Ranking TTM	# 3526	# 3764	# 3736	# 0	# 0
Seq. Current Liabilities TTM Growth	20.05 %	12.48 %	34.55 %	46.3 %	92.59 %
Seq. Cash & cash equivalent TTM Growth	-40.79 %	0 %	-5.37 %	23.37 %	1246.59 %

Quick ratio ranking by company, industry and sector >> Back to DRNK Financial Strength Comparisons >> Go to Compare DRNK Quick Ratio to its Competitors

On the trailing twelve months basis Due to unchanged in Current Liabilities in the Q3 2014 to $3.56 millions, cumulative Quick Ratio decreased to 0.01 below the Noho, Inc. average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 44 other companies have achieved higher Quick Ratio than Noho. While Quick Ratio overall ranking has improved so far to 3526, from total ranking during the twelve months ending second quarter 2014 at 3764.

Explain Quick Ratio?
How much Cash & cash equivalents DRNK�s has?
What are DRNK�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Biotechnology & Pharmaceuticals Industry	# 45
Healthcare Sector	# 396
Within the Market	# 3526

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.02	0.02	0.01
		(Sep 30 2014)

Companies with similar Quick Ratio in the quarter ending Sep 30 2014, within Biotechnology & Pharmaceuticals Industry	Quick Ratio	Sep 30 2014 MRQ Cash & cash equivalent	Sep 30 2014 MRQ Current Liabilities
Point Of Care Nano technology Inc	0.05	$ 0.014 Millions	$ 0.262 Millions
Gene Biotherapeutics Inc	0.04	$ 0.072 Millions	$ 1.667 Millions
Cullinan Therapeutics Inc	0.04	$ 0.002 Millions	$ 0.050 Millions
Mymetics Corporation	0.03	$ 1.343 Millions	$ 50.599 Millions
Noho, Inc.	0.02	$ 0.072 Millions	$ 3.558 Millions
Oncovista Innovative Therapies, Inc	0.02	$ 0.076 Millions	$ 4.211 Millions
Spotlight Innovation Inc.	0.02	$ 0.041 Millions	$ 2.445 Millions
Zivo Bioscience Inc	0.01	$ 0.102 Millions	$ 9.155 Millions
Creative Medical Technology Holdings Inc	0.01	$ 0.001 Millions	$ 0.148 Millions
Glucose Health, Inc.	0.00	$ 0.001 Millions	$ 0.204 Millions

Date modified: 2026-09-08T15:21:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.